Most cases occur in southern-tier U.S. states during summer months, but infections have been reported in northern states as water temperatures rise. The amoeba thrives in lakes, rivers, hot springs, and poorly maintained recreational water facilities where temperatures exceed 80°F (27°C). Climate change and extended heat waves are expanding the geographic range and seasonal window for Naegleria fowleri activity, increasing exposure risk for communities in previously unaffected areas WHO fact sheet on Naegleria fowleri.
Symptoms, Diagnosis, and Why the Infection Is So Deadly
Early symptoms of PAM appear one to twelve days after exposure and include severe headache, fever, nausea, and vomiting. Within days, the infection progresses to stiff neck, confusion, loss of balance, seizures, and hallucinations, often leading to coma and death within one to eighteen days of symptom onset. Because initial symptoms resemble bacterial or viral meningitis, misdiagnosis is common, and treatment is frequently delayed until the disease has advanced significantly Mayo Clinic PAM symptoms and diagnosis.
Diagnosis requires specialized laboratory testing, including cerebrospinal fluid analysis, PCR, and imaging to detect brain swelling and tissue destruction. Hospitals use a combination of antimicrobial drugs, including intravenous amphotericin B, miltefosine, and aggressive cooling protocols, but these interventions rarely reverse the damage once the infection is established. The CDC maintains a rapid-response team and provides diagnostic support to clinicians, yet the overall fatality rate remains above 97% in the United States since 1962 CDC healthcare provider guidance.
Recent Fatal Case, Public Response, and Prevention Measures
A recent fatal case involved a man who contracted Naegleria fowleri while swimming in a warm freshwater body, leading to rapid neurological decline and death within days. Local health departments traced the exposure to a lake or river with elevated water temperatures and low water levels, conditions that concentrate the amoeba. The incident prompted warnings from state and federal health agencies about avoiding nasal contact with untreated warm freshwater and using nose clips during water activities FDA approval of miltefosine for PAM treatment.
Prevention focuses on avoiding submersion of the head in untreated warm freshwater, using nose clips,